OrsoBio, Inc.
- Biotech or pharma, therapeutic R&D
OrsoBio, Inc. is a privately held, clinical-stage biopharmaceutical company dedicated to developing therapies to treat severe metabolic disorders, including type 2 diabetes, severe dyslipidemias, lipodystrophies, and nonalcoholic steatohepatitis. OrsoBio currently has four programs in clinical and preclinical development with first-in-class compounds that address central pathways in energy metabolism.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}